Biased IL2 muteins methods and compositions
US11491205B2 · kind B2 · utility
2Cited by
96References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2021 |
| Grant date | Nov 8, 2022 |
| Priority date | — |
| Expiry date | Jan 14, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosures related to human interleukin-2 (hIL2) muteins, pharmaceutical formulations thereof, methods for preparing interleukin-2 muteins, recombinant vectors and cells comprising nucleic acids encoding IL2 muteins and methods for the treatment of human disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.